Anticorps Monoclonal anti-CDKN2A/P16-INK4A
CDKN2A/P16-INK4A Monoclonal Antibody for WB, IHC, IF/ICC, Indirect ELISA
Hôte / Isotype
Mouse / IgG2a
Réactivité testée
Humain
Applications
WB, IHC, IF/ICC, Indirect ELISA
Conjugaison
Non conjugué
CloneNo.
1C9D3
N° de cat : 60626-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
60626-1-PBS cible CDKN2A/P16-INK4A dans les applications de WB, IHC, IF/ICC, Indirect ELISA et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Hôte / Isotype | Mouse / IgG2a |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | CDKN2A/P16-INK4A Protéine recombinante Ag1328 |
Nom complet | cyclin-dependent kinase inhibitor 2A |
Masse moléculaire calculée | 16 kDa |
Poids moléculaire observé | 16 kDa |
Numéro d’acquisition GenBank | BC021998 |
Symbole du gène | CDKN2A |
Identification du gène (NCBI) | 1029 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par protéine A |
Tampon de stockage | PBS only |
Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
P16-INK4A is also named as CDKN2A, MLM, Tumor suppressor ARF, Alternative reading frame. The tumor suppressor protein p16Ink4a (encoded from the CDKN2A locus) is often transcriptionally activated in cells undergoing senescence and is one of the main regulators of this program, and it is upregulated in multiple tissues during aging (PMID:17055429). p16-Ink4a is the principal member of the Ink4 family of CDK inhibitors. p16-Ink4a contributes to the regulation of cell cycle progression by inhibiting the S phase. p16Ink4a binds to CDK4/6, inhibiting cyclin D-CDK4/6 complex formation and CDK4/6-mediated phosphorylation of Rb family members. Expression of p16-Ink4a maintains the Rb family members in a hypophosphorylated state, which promotes binding to E2F1 and leads to G1 cell cycle arrest (PMID: 21297668).